GIBSON LANE PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: B86036 | LEEDS, LS25 7JN
Showing results 401-450 of 669
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 36 | 652 | £1.1K | +30.1% ▲ | |
| 36 | 3,490 | £727 | +39.6% ▲ | |
| Eslicarbazepine acetate | 35 | 1,374 | £2.8K | +56.8% ▲ |
| Light liquid paraffin | 35 | 12.6K | £270 | +2.8% ▲ |
| Betamethasone esters | 35 | 1,960 | £219 | -42.0% ▼ |
| 35 | 1,827 | £3.2K | +97.3% ▲ | |
| 35 | 94 | £1.9K | +153.4% ▲ | |
| Eprosartan | 34 | 1,148 | £462 | +68.4% ▲ |
| Alimemazine tartrate | 34 | 2,944 | £7.3K | +163.0% ▲ |
| Galantamine | 34 | 952 | £1.5K | -10.2% ▼ |
| Water for injection | 34 | 335 | £103 | +0.5% vs avg |
| Zinc oxide | 34 | 11.0K | £306 | +69.1% ▲ |
| 34 | 1,080 | £795 | +2.8% ▲ | |
| Atropine sulfate | 33 | 1,496 | £1.2K | +159.0% ▲ |
| Terbinafine hydrochloride | 33 | 1,050 | £197 | -11.1% ▼ |
| Oral rehydration salts | 32 | 6,164 | £2.6K | +10.8% ▲ |
| Indometacin | 32 | 3,039 | £204 | +103.4% ▲ |
| 32 | 395 | £1.6K | -27.2% ▼ | |
| 32 | 2,029 | £933 | +8.9% ▲ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 31 | 1,680 | £246 | -10.9% ▼ |
| Guanfacine | 31 | 1,036 | £2.2K | +20.7% ▲ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 31 | 840 | £70 | +106.3% ▲ |
| 31 | 380 | £516 | +220.9% ▲ | |
| 31 | 990 | £3.7K | +163.9% ▲ | |
| Lorazepam | 30 | 662 | £150 | -79.0% ▼ |
| Biphasic insulin lispro | 30 | 510 | £3.1K | -30.1% ▼ |
| Cinacalcet hydrochloride | 30 | 1,456 | £777 | +29.3% ▲ |
| Brinzolamide and timolol | 30 | 230 | £304 | -20.6% ▼ |
| 30 | 3,454 | £168 | +132.5% ▲ | |
| 30 | 1,690 | £6.5K | -33.7% ▼ | |
| 30 | 500 | £1.2K | +46.3% ▲ | |
| Etonogestrel | 29 | 29 | £2.4K | +0.3% vs avg |
| Miconazole nitrate | 29 | 1,180 | £176 | -59.0% ▼ |
| 29 | 455 | £176 | +0.1% vs avg | |
| 29 | 2,722 | £2.9K | -65.9% ▼ | |
| Co-tenidone (Atenolol/chlortalidone) | 28 | 1,260 | £123 | +34.3% ▲ |
| Dexamfetamine sulfate | 28 | 2,744 | £2.2K | -22.1% ▼ |
| Ryeqo | 28 | 784 | £1.9K | +397.4% ▲ |
| 28 | 1,126 | £352 | +38.5% ▲ | |
| 28 | 81 | £582 | +120.1% ▲ | |
| Simple | 27 | 5,400 | £47 | +135.2% ▲ |
| Leflunomide | 27 | 810 | £51 | -28.7% ▼ |
| Febuxostat | 27 | 1,036 | £133 | -27.7% ▼ |
| Fluorometholone | 27 | 180 | £56 | +87.4% ▲ |
| Menthol | 27 | 11.7K | £433 | -4.1% ▼ |
| Cimetidine | 26 | 2,160 | £237 | +39.4% ▲ |
| Dabigatran etexilate | 26 | 1,560 | £1.2K | -49.8% ▼ |
| Temazepam | 26 | 1,854 | £1.6K | -54.5% ▼ |
| Primidone | 26 | 2,040 | £2.7K | -26.9% ▼ |
| Amantadine hydrochloride | 26 | 1,512 | £378 | -6.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.